1-855-378-42281-855-378-4228
One of the out-patient rehabilitation alternatives for people in Sea Cliff who are battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are authorized to dispense certain meds to opioid dependent individuals, many that are opioid-based also and are addiction. With low enough doses the client doesn't experience high feelings and also doesn't experience severe cravings and isn't experiencing opioid withdrawal. Methadone is the first medication administered for this purpose, but there are other options currently to choose from.
Methadone is an opiate and is meant to be taken at an out-patient clinic certified to dispense the drug, which is taken on a daily basis in liquid or pill form. The cost of the drug is around one hundred and fifty dolloars a month. Buprenorphine is also an opiate based med, and is a pill often taken every other day. But unlike Methadone which can only be dispensed in structured clinics, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The price monthly of buprenorphine is approximately three hundred dollars /month for the generic version of the drug. There is also a version of buprenorphine that contains naloxone, that is a med that blocks the effects of opiates. An individual taking this version of the drug, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced about $450 per month. Naltrexone is another drug taken in opioid maintenance therapy, but unlike the other drugs mentioned here it's an opioid blocker and isn't an opioid. A person has the choice to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents someone from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 /month.
For All Alcohol and Drug Rehabilitation Programs In Sea Cliff, Click Here.
